296 related articles for article (PubMed ID: 2044645)
1. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
Einarsson K; Ericsson S; Ewerth S; Reihnér E; Rudling M; Ståhlberg D; Angelin B
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S53-8. PubMed ID: 2044645
[TBL] [Abstract][Full Text] [Related]
2. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
Benson GM; Alston DR; Bond BC; Gee AN; Glen A; Haynes C; Hickey DM; Iqbal S; Jackson B; Jaxa-Chamiec AA
Atherosclerosis; 1993 Jun; 101(1):51-60. PubMed ID: 8216502
[TBL] [Abstract][Full Text] [Related]
3. Modeling plasma lipoprotein-bile lipid relationships: differential impact of psyllium and cholestyramine in hamsters fed a lithogenic diet.
Trautwein EA; Siddiqui A; Hayes KC
Metabolism; 1993 Dec; 42(12):1531-40. PubMed ID: 8246766
[TBL] [Abstract][Full Text] [Related]
4. Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat.
Shefer S; Nguyen LB; Salen G; Ness GC; Chowdhary IR; Lerner S; Batta AK; Tint GS
J Lipid Res; 1992 Aug; 33(8):1193-200. PubMed ID: 1431598
[TBL] [Abstract][Full Text] [Related]
5. Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption.
Bertolotti M; Zambianchi L; Carulli L; Simonini MS; Del Puppo M; Kienle MG; Loria P; Pinetti A; Carulli N
Hepatology; 2003 Oct; 38(4):939-46. PubMed ID: 14512881
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
Reihnér E; Angelin B; Rudling M; Ewerth S; Björkhem I; Einarsson K
J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
[TBL] [Abstract][Full Text] [Related]
7. Alteration of biliary ursodeoxycholic acid in guinea pig during early stages of cholestyramine feeding.
Li JR; Dinh DM; Kottke BA
Steroids; 1979; 34(6 Spec no):705-15. PubMed ID: 538776
[TBL] [Abstract][Full Text] [Related]
8. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase.
Pandak WM; Vlahcevic ZR; Heuman DM; Redford KS; Chiang JY; Hylemon PB
Hepatology; 1994 Apr; 19(4):941-7. PubMed ID: 8138269
[TBL] [Abstract][Full Text] [Related]
9. Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men.
Carrella M; Ericsson S; Del Piano C; Angelin B; Einarsson K
J Intern Med; 1991 Mar; 229(3):241-6. PubMed ID: 2007842
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment.
Suckling KE; Benson GM; Bond B; Gee A; Glen A; Haynes C; Jackson B
Atherosclerosis; 1991 Aug; 89(2-3):183-90. PubMed ID: 1793446
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol gallstones and biliary lipid metabolism in the primate.
Redinger RN; Grace DM
Gastroenterology; 1978 Feb; 74(2 Pt 1):201-4. PubMed ID: 413761
[TBL] [Abstract][Full Text] [Related]
12. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters.
Trautwein EA; Forgbert K; Rieckhoff D; Erbersdobler HF
Biochim Biophys Acta; 1999 Jan; 1437(1):1-12. PubMed ID: 9931405
[TBL] [Abstract][Full Text] [Related]
13. Cholestyramine alters bile acid amounts and the expression of cholesterol-related genes in rabbit intestinal and hepatic tissues.
Qiu DN; Shang Q; Sun DY; Ding WQ; Luo ZG; Chen J; Jiang WR; Huang JP; Jiang XY
J Dig Dis; 2017 Feb; 18(2):107-114. PubMed ID: 28067465
[TBL] [Abstract][Full Text] [Related]
14. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
15. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo.
Bertolotti M; Abate N; Loria P; Dilengite M; Carubbi F; Pinetti A; Digrisolo A; Carulli N
Hepatology; 1991 Nov; 14(5):830-7. PubMed ID: 1937389
[TBL] [Abstract][Full Text] [Related]
16. Bile acid sequestrants.
Ast M; Frishman WH
J Clin Pharmacol; 1990 Feb; 30(2):99-106. PubMed ID: 2179278
[TBL] [Abstract][Full Text] [Related]
17. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat.
Felgines C; Mazur A; Rayssiguier Y
Life Sci; 1994; 55(13):1053-60. PubMed ID: 8084210
[TBL] [Abstract][Full Text] [Related]
18. Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree rats.
Gustafsson BE; Angelin B; Einarsson K; Gustafsson JA
J Lipid Res; 1978 Nov; 19(8):972-7. PubMed ID: 731132
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of rat liver parenchyma in cholesterol 7 alpha-hydroxylase and bile acid synthesis.
Ugele B; Kempen HJ; Kempen JM; Gebhardt R; Meijer P; Burger HJ; Princen HM
Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):73-7. PubMed ID: 2039484
[TBL] [Abstract][Full Text] [Related]
20. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.
Hillebrant CG; Nyberg B; Einarsson K; Eriksson M
Gut; 1997 Nov; 41(5):700-4. PubMed ID: 9414982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
